Spirulan from Blue-Green Algae Inhibits Fibrin and Blood Clots: Its Potent Antithrombotic Effects

Journal of Biochemical and Molecular Toxicology

Volumn 29, Issue 5, 2015, Pages 240-248

  Choi, Jun Hui ^a   Kim, Seung ^b   Kim, Sung Jun ^a  

^a Chosun University   (South Korea)

^b Kwangju University   (South Korea)

Author keywords

Anti procoagulant protein activity; Antithrombotic activity; Arthrospira platensis; Fibrinolytic activity; Spirulan

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; FERRIC CHLORIDE; FIBRIN; FIBRINOGEN; POLYSACCHARIDE SULFATE; SPIRULAN; THROMBIN; UNCLASSIFIED DRUG; FIBRINOLYTIC AGENT; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTHROSPIRA PLATENSIS; ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HEMOLYSIS; HEMOSTASIS; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD CLOTTING; CHEMISTRY; CYANOBACTERIUM; DRUG EFFECTS; HUMAN; PATHOLOGY; THROMBOSIS;

ARTHROSPIRA PLATENSIS; CHLOROPHYTA; CYANOBACTERIA;

ANIMALS; BLOOD COAGULATION; CYANOBACTERIA; FIBRIN; FIBRINOGEN; FIBRINOLYTIC AGENTS; HUMANS; MICE; POLYSACCHARIDES; THROMBOSIS;

EID: 84929050479     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21690     Document Type: Article

References (42)

1. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000;149:251-266.
2. Weisel JW, Stauffacher CV, Bullitt E, Cohen C. A model for fibrinogen: domains and sequence. Science 1985;230:1388-1391.
3. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991;78:3114-3124.
4. Cannon CP, McCacbe CH, Gibson M, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy RP, Love TW, Braunwald E. TNK-tissue plasminogen activator in acute myocardial infarction of the thrombolysis in myocardial infarction (TIMI) 10A dose ranging Trial. Circulation 1997;95:351-356.
5. Iqbal O, Tobu M, Demyr M, Fareed J, Aziz S, Messmore H. The role of thrombolytic drugs in the management of acute myocardial infarction and stroke. Turk J Haematol 2002;19:151-177.
6. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451:914-918.
7. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. CHEST 1995;108:258S-275S.
8. Church FC, Meade JB, Treanor RE, Whinna HC. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem 1989;264:3618-3623.
9. Matsubara K, Matsuura Y, Bacic A, Liao ML, Hori K, Miyazawa K. Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum. Int J Biol Macromol 2001;28:395-399.
10. Maruyama H, Tamauchi H, Hashimoto M, Nakano T. Antitumor activity and immune response of Mekabu fucoidan extracted from sporophyll of Undaria pinnatifida. In Vivo 2003;17:245-249.
11. Preeprame S, Hayashi K, Lee JB, Sankawa U, Hayashi T. A novel antivirally active fucan sulfate derived from an edible brown alga, Sargassum horneri. Chem Pharm Bull 2001;49:484-485.
12. Béguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost 1988;60:457-462.
13. Doctor VM, Lewis D, Coleman M, Kemp MT, Marbley E, Sauls V. Anticoagulant properties of semisynthetic polysaccharide sulfates. Thromb Res 1991;64(4):413-425.
14. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 1: heparin. American Heart Association. Circulation 1994;89:1449-1468.
15. Beijering RJ, ten Cate H, ten Cate JW. Clinical applications of new antithrombotic agents. Ann Hematol 1996;72:177-183.
16. Han N, Gu Y, Ye C, Cao Y, Liu Z, Yin J. Antithrombotic activity of fractions and components obtained from raspberry leaves (Rubus chingii). Food Chem 2012;132:181-185.
17. Wang Y, Shao J, Yao S, Zhang S, Yan J, Wang H, Chen Y. Study on the antithrombotic activity of Umbilicaria esculenta polysaccharide. Carbohydr Polym 2014;105:231-236.
18. Majdoub H, Ben Mansour M, Chaubet F, Roudesli MS, Maaroufi RM. Anticoagulant activity of a sulfated polysaccharide from the green alga Arthrospira platensis. Biochim Biophys Acta 2009;1790(10):1377-1381.
19. Lee JB, Hayashi T, Hayashi K, Sankawa U, Maeda M, Nemoto T, Nakanishi H. Further purification and structural analysis of calcium spirulan from Spirulina platensis. J Natural Products 1998;61:1101-1104.
20. Lee JB, Hayashi T, Hayashi K, Sankawa U. Structural analysis of calcium spirulan (Ca-SP)-derived oligosaccharides using electrospray ionization mass spectrometry. J Natural Products 2000;63:136-138.
21. Hayakawa Y, Hayashi T, Hayashi K, Ozawa T, Niiya K, Sakuragawa N. Calcium spirulan as an inducer of tissue-type plasminogen activator in human fetal lung fibroblasts. Biochim Biophys Acta 1997;1355:241-247.
22. Astrup T, Mullertz S. The fibrin plate method for estimating of fibrinolytic activity. Arch Biochem Biophys 1952;40:346-351.
23. Kim SH, Choi NS, Lee WY. Fibrin zymography: a direct analysis of fibrinolytic enzymes on gels. Ann Biochem 1998;263:115-116.
24. Matsubara K, Hori K, Matsuura Y, Miyazawa K. Purification and characterization of a fibrinolytic enzyme and identification of fibrinogen clotting enzyme in a marine green alga, Codium divaricatum. Comp Biochem Physiol 2000;125:137-143.
25. Gaspar AR, Crause JC, Neitz AW. Identification of anticoagulant activities in the salivary glands of the soft tick, Ornithodoros savignyi. Exp Appl Acarol 1995;19:117-127.
26. Klafke JZ, Arnoldi da Silva M, Fortes Rossato M, Trevisan G, Banderó Walker CI, Martins Leal CA, Olschowsky Borges D, Chitolina Schetinger MR, Noal Moresco R, Medeiros Frescura Duarte MM, Soares Dos Santos AR, Nazário Viecili PR, Ferreira J. Antiplatelet, antithrombotic, and fibrinolytic activities of Campomanesia xanthocarpa. Evid Based Compl Alternat Med 2012;2012:954748.
27. DiMinno G, Silver MJ. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther 1983;225:57-60.
28. Wang X, Cheng Q, Xu L, Feuerstein GZ, Hsu MY, Smith PL, Seiffert DA, Schumacher WA, Ogletree ML, Gailani D. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 2005;3:695-702.
29. Tucker EL, Verbout NG, Leung PY, Hurst S, McCarty OJ, Gailani D, Gruber A. Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis. Blood 2012;119:4762-4768.
30. McLellan DS, Jurd KM. Anticoagulants from marine algae. Blood Coagul Fibrinol 1992;3:69-77.
31. Wang Y, Shao J, Yao S, Zhang S, Yan J, Wang H, Chen Y. Study on the antithrombotic activity of Umbilicaria esculenta polysaccharide. Carbohydr Polym 2014;105:231-236.
32. Li CY, Zhang XY, Zhao M, Wang YJ, Wu JH, Liu JW, Zheng M, Peng S. A class of novel N-(1-methyl-β-carboline-3-carbonyl)-N'-(aminoacid-acyl)-hydrazines: aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis. Eur J Med Chem 2011;46:5598-5608.
33. Rana A, Zeynep B, Nurcan B, Ali HM, Yusuf O. Antithrombotic effects of ethanol extract of Crataegus orientalis in the carrageenan-induced mice tail thrombosis model. Thromb Res 2011;127:210-213.
34. Sa YS, Kim SJ, Choi HS. The anticoagulant fraction from the leaves of Diospyros Kaki L. has an antithrombotic activity. Arch Pharm Res 2005;28:667-674.
35. Xie L, Chen MH, Li J, Yang XM, Huang QJ. Antithrombotic effect of a polysaccharide fraction from Laminaria japonica from the South China Sea. Phytother Res 2011;25:1362-1366.
36. Fan YQ, Wu QH, Sheng JH. Study on the antithrombotic effect of polysaccharide of Auricularia auriculajudae. Chin J Biochem Pharmaceut 2009;30:410-412.
37. Sokolova EV, Byankina AO, Kalitnik AA, Kim YH, Bogdanovich LN, Solov'eva TF, Yermak IM. Influence of red algal sulfated polysaccharides on blood coagulation and platelets activation in vitro. J Biomed Mater Res A 2014;102:1431-1438.
38. Dore CM, das C Faustino Alves MG, Will LS, Costa TG, Sabry DA, de Souza Rêgo LA, Accardo CM, Rocha HA, Filgueira LG, Leite EL. A sulfated polysaccharide, fucans, isolated from brown algae Sargassum vulgare with anticoagulant, antithrombotic, antioxidant and anti-inflammatory effects. Carbohydr Polym 2013;91:467-475.
39. Mourão PA. Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives. Cur Pharmaceut Design 2004;10(9):967-981.
40. Bertolin TE, Pilatti D, Giacomini ACVV, Bavaresco CS, Colla LM, Costa JAV. Effect of microalga Spirulina platensis (Arthrospira platensis) on hippocampus lipoperoxidation and lipid profile in rats with induced hypercholesterolemia. Braz Arch Biol Technol 2009;52:1253-1259.
41. Henry BL, Monien BH, Bock PE, Desai UR. A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. J Biol Chem 2007;282:31891-31899.
42. Leadley RJ Jr, Chi L, Rebello SS, Gagnon A. Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. J Pharmacol Toxicol Methods 2000;43:101-116.